We combine in-depth medical knowledge with capital markets competence across all product areas.
Promising frontier technology
Life sciences and biotechnology are widely regarded as one of the most promising frontier technologies for the coming decades.
The Norwegian life sciences industry is evolving rapidly. Having previously operated in the shadow of successful company clusters in Sweden and Denmark, Norwegian life sciences companies are now increasingly being recognized in their own right and attracting attention and interest from all over the world.
Continued research and development (R&D) by research centers in hospitals and universities in Norway is expected to contribute to the further development of the life sciences industry over the next decade. We expect growth in all relevant segments and particularly within oncology.
Arctic Securities has dedicated significant resources to the sector and has been involved in most of the Norwegian transactions within the life sciences sector over the last years.
Read more about our services in this sector
Arctic Securities is a leading corporate finance advisor and transaction manager with extensive experience and expertise from the Nordic market. We offer our clients financial services including equity (ECM) and debt (DCM) capital markets, mergers & acquisitions (M&A), corporate restructurings and structured finance.
Fixed Income & Equity Sales
Arctic Securities’ Equity and Fixed Income Sales team consists of experienced salespeople with an extensive client base among Nordic, US, UK, and other international institutions.
Arctic Aurora LifeScience and Arctic Aurora Biotech Select is a specialized global healthcare UCITS fund. The funds invests in the most innovative pharmaceutical and biotech companies developing new treatments that significantly changes the life of patients to the benefit for society.
Head of Corporate Finance
Head of Sales
Chief Executive Officer